Pacific Biosciences of California PACB Service — Deferred Revenue (Non-Current)
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's service — deferred revenue (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's service — deferred revenue (non-current)?
- Pacific Biosciences of California (PACB) reported service — deferred revenue (non-current) of $3.6M in Q1 2026.
- How has Pacific Biosciences of California's service — deferred revenue (non-current) changed year-over-year?
- Pacific Biosciences of California's service — deferred revenue (non-current) decreased by 39.0% year-over-year, from $5.9M to $3.6M.
- What does service — deferred revenue (non-current) mean?
- This reflects the portion of service-related payments received in advance that are expected to be recognized as revenue beyond the next twelve months. It provides insight into the long-term visibility of the company's service business and the duration of multi-year support agreements. High levels of non-current deferred revenue indicate strong long-term customer commitment to the company's platform.